Equity Markets — Page 6
Page 6 of the Equity Markets archive on FinancialMarkets.com.
Latest articles
- KKR's Record $250 Million Penalty Covers More Than Sixteen Separate Deals
- Rivian's CFO Is Leaving Right As Its Hardest Production Stretch Begins
- Meta's Teen-Safety Settlement Comes With a Number That Depends on Who's Counting
- A Small Humanoid-Robotics Company Just Swapped CEOs With No Explanation Given
- AWS Burned Through GPUs | Anthropic Abandoned MatX | Collins Shifts Hawkish | Tech Calls for AI Defense
- The company AI was supposed to kill just had its second-best day ever
- Nvidia rallied 9%. Marvell beat and dropped 7%. Same week.
- Nvidia's Hidden Obligations | Global Bond Rout | AI Rotation | JPM Funds Volta
- Nvidia Rallied 8.7%. The Average Tech Stock Fell.
- AWS Blew Through a Year of Nvidia GPU Supply in Under Five Months. The Stock That Should Have Cheered Fell Anyway.
- Vicor's New $150 Million Buyback Arrives 47% Below Its High, With No Explanation Attached
- Four Canadian Banks Posted Strong Quarters This Week. Their Stocks Didn't Agree on What That Meant.
- Prudential Is Selling Down Its India Stake. The Reason Has Nothing to Do With Performance.
- Nvidia Is Reportedly Paying $12.9 Billion for Hugging Face. Its Own Earnings Are Getting Credit for the Stock Move Instead.
- HF Sinclair Had $11 Million Left in Its Buyback Budget. It Just Authorized $1.5 Billion More.
- Nvidia Beat and Warned | 700 Agents Hacked OpenAI | SaaS Beats | Anthropic's Deal
- Nvidia buried the real number
- Nvidia proved the AI trade. PCE proved the problem.
- PCE Hike Odds Jump | Warsh's Unanswered Question | Meta's $18B Deal
- Alibaba's $10.2 Billion Share Sale Is Now Fully Settled. The Dilution Bill Already Came Due Last Week.
- Biohaven's "$795 Million" Deal Is Really $400 Million in Cash. The Rest Is Someone Else's Debt.
- Spyre's Drug Beat Placebo on Every Measure. The Company Still Called It a Miss.
- Meta Agreed to Pay Up to $17.1 Billion to Settle Child-Safety Claims. The Stock's Reaction Says the Story Isn't Over.
- H.B. Fuller Says Its Board Rejected Ancora's Bid on the Merits. The Stock Says Investors Aren't So Sure.